Research ArticleNEUROPHARMACOLOGY
Pharmacological Characterization of a Novel, Potent Adenosine A1 and A2A Receptor Dual Antagonist, 5-[5-Amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in Models of Parkinson's Disease and Cognition
Takuma Mihara, Kayoko Mihara, Junko Yarimizu, Yasuyuki Mitani, Ritsuko Matsuda, Hiroko Yamamoto, Satoshi Aoki, Atsushi Akahane, Akinori Iwashita and Nobuya Matsuoka
Journal of Pharmacology and Experimental Therapeutics November 2007, 323 (2) 708-719; DOI: https://doi.org/10.1124/jpet.107.121962
Takuma Mihara
Kayoko Mihara
Junko Yarimizu
Yasuyuki Mitani
Ritsuko Matsuda
Hiroko Yamamoto
Satoshi Aoki
Atsushi Akahane
Akinori Iwashita
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleNEUROPHARMACOLOGY
Pharmacological Characterization of a Novel, Potent Adenosine A1 and A2A Receptor Dual Antagonist, 5-[5-Amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in Models of Parkinson's Disease and Cognition
Takuma Mihara, Kayoko Mihara, Junko Yarimizu, Yasuyuki Mitani, Ritsuko Matsuda, Hiroko Yamamoto, Satoshi Aoki, Atsushi Akahane, Akinori Iwashita and Nobuya Matsuoka
Journal of Pharmacology and Experimental Therapeutics November 1, 2007, 323 (2) 708-719; DOI: https://doi.org/10.1124/jpet.107.121962
Research ArticleNEUROPHARMACOLOGY
Pharmacological Characterization of a Novel, Potent Adenosine A1 and A2A Receptor Dual Antagonist, 5-[5-Amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in Models of Parkinson's Disease and Cognition
Takuma Mihara, Kayoko Mihara, Junko Yarimizu, Yasuyuki Mitani, Ritsuko Matsuda, Hiroko Yamamoto, Satoshi Aoki, Atsushi Akahane, Akinori Iwashita and Nobuya Matsuoka
Journal of Pharmacology and Experimental Therapeutics November 1, 2007, 323 (2) 708-719; DOI: https://doi.org/10.1124/jpet.107.121962
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement